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Dubos and his coworkers recently have shown the profound influence that 
certain surface-active oleates have on the in vitro growth of the tubercle bacillus 
(1-3).  Their work suggests that by the addition of these fatty acid in a highly 
surface-active form a  great  enhancement  of  growth  can  be obtained.  The 
mechanism of action of this surface-active growth-promoting factor has been 
interpreted  according  to  known  physical-chemical  principles,  which  would 
indicate that the oleate is concentrated at the periphery of, or within the con- 
fines of the mycobacterium. 
In  the  study  here  to  be  reported,  1 several  surface-active  tuberculostafic 
substances have been prepared and tested in an effort to determine whether a 
similar increased effect on the tubercle bacillus would be obtained by concen- 
trating an inhibitory instead of a  stimulating  substance about the organism. 
These substances were found to be effective in vitro in relatively low concen- 
trations. 
The mechanism of such tuberculostatic action was investigated according to 
physical-chemical principles, by isolating the factor of drug action due to its 
surface activity from its inherent (non-surface-active) component.  This was 
carried out by introducing a  substance antagonistic to the surface-active com- 
ponent of the drug, but in no other way interfering with its antibacterial action. 
These studies suggest that the property of surface activity may enchance the 
tuberculostatic action of a given drug.  The reason for such action is discussed 
and correlated with the steric arrangement of the drug molecule in relation to 
the surface of the mycobacterium.  Other previously described surface-active 
tuberculostafic chemicals and antibiotics have also been studied with this con- 
cept in mind, and certain of them are shown to owe a part of their activity to 
the surface-active character of their molecules. 
Hypothethical  Effect  of  Surface-Active  Substances  upon  Mycobacteria.--In 
general, studies of the effects of surface-active substances upon the growth of 
bacteria and  of acid-fast organisms in particular  (4--8) have emphasized the 
fact that human tubercle bacilli can grow in vitro at a  vastly reduced surface 
11 wish to thank Dr. Evarts Graham, Dr. W. Barry Wood,  and Dr. J. Bronfenbreaner  for 
their help and assistance throughout the planning and execution  of this study. 
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tension, most authors agreeing that growth is possible at 35 to 40 dynes per 
sq. cm.  It was shown that under such conditions the growth of the organisms 
which normally occurs as a surface pellicle would submerge in liquid medium. 
Other characteristics of bacteria were also noted in  the presence of surface- 
active  substances,  such  as  variations  in  pathogenicity  (8),  and  the  anti- 
swarming  effect on B.  proteus (9).  Stanley  (10)  has  commented  upon  the 
correlation between known leprocidal agents, and their ability to lower surface 
tension, suggesting that the "soapiness"  of solutions of these chemotherapeutic 
agents might in some way account for their bacteriostatic action. 
Dubos (1) in 1945 first showed the remarkable stimulating effect that water- 
soluble lipids in the form of a  surface-active agent could have on the in vitro 
growth of the tubercle bacillus.  He used a phospholipid (which is a naturally 
~kG. 1.  Proposed orientation of Tween 80 molecule upon surface of tubercle bacillus 
occurring surface-active substance) as well as a synthetic commercially available 
surface-active agent, Tween 80.  The addition of such a  surface-active agent 
in concentration of 50 mg. per cent reduced the time required for growth in a 
liquid medium to less than a week.  Many surface-active substances were tried 
before tests led to the choice of Tween 80.  In particular Dubos (11) has shown 
that the stimulating effect is inherent in the hydrophobic end of the Tween 80 
molecule, which is an oleate.  The remaining portion of the molecule is merely a 
water-solubilizing complex, which in the case of Tween 80 consists of a sorbitan 
nucleus attached to three polyethylene glycol chains. 
If the known properties of surface-active substances be applied to the Tween 
80 molecule, its steric arrangement about the tubercle bacillus can be illustrated 
as in Fig. 1.  This surface-active molecule will concentrate around the water- 
bacillus interface, with the hydrophobic portion of the molecule (the oleate) 
placed toward or pushed within the bacterium.  The exact chemical nature of 
the structures on the periphery of the tubercle bacillus is under critical consid- Bo  EISEMAN  191 
eration at  the present time.  Whether a true fatty capsule, a lipid layer, or a 
lipoprotein complex exists is debatable  (12), but as far as this study is con- 
cerned is of little consequence.  Whatever its nature, at least an interface is 
formed which on one side is aqueous and on the other is high in lipid content 
(13).  It  is  at  this  interface  that  the  surface-active  molecules  adlineate. 
Whether actual penetration of this lipid layer is attained is only problematic. 
One of the actions of the Tween 80 molecule in Dubos' media therefore may 
be that of concentrating a known metabolite (the oleate) at a  point where it 
would be most readily available to the organism, namely at the periphery of, 
or possibly within the confines of the bacterial cell.  By dispersing the normally 
clumped tubercle bacilli, Tween 80 asserts another type of stimulating effect 
upon bacterial growth. 
Instead  of  concentrating  an  essential  metabolite  at  the  tubercle  bacillus 
boundary, as in the case of Tween 80, it was anticipated that a known tuber- 
culostatic substance might be used as the hydrophobic end of a surface-active 
molecule.  In  this way the effective concentration of the drug might be in- 
creased, for the surface-active molecules instead of being spread evenly through- 
out the solution would adlineate about the periphery of the bacteria.  Many 
compounds have been shown to be effective in vitro against the tubercle bacillus 
(14).  Of these, among the best known and most thoroughly investigated are 
the diaminodiphenyl sulfone derivatives.  Promin, promizole, and diasone are 
some  of  the  derivatives  that  have  been  produced  commercially from  this 
mother compound.  Because of the availability of this compound, its rather 
simple chemistry, and because of its water-insoluble nature, diaminodiphenyl 
sulfone was  used  as  the  tuberculostatic  compound  with  which  to  test  this 
hypothesis of drug action.  By attaching  a  water-soluble component to one 
end of the diaminodiphenyl sulfone in such a way as to solubilize in a balanced 
manner the molecule, a  surface-active drug fitting the requirements could be 
obtained.  Fig.  2 a  illustrates a  surface-active oleate, such as would enhance 
the growth of the tubercle bacillus.  Figs. 2 b and 2 c represent an analogous 
surface-active sulfone which could act in a like manner to inhibit mycobacterial 
metabolism.  In order to assure the orientation of the drug molecules, some of 
the drugs were compounded with the active sulfone attached to the end of an 
already surface-active molecule, as illustrated in Fig. 2 c. 
Investigation  of Mechanism of Drug Action.--If the principles of drug action 
upon  which  these  materials  were  prepared  were  correct,  the  surface-active 
agents should assert a  tuberculostatic effect at a  relatively low concentration. 
Mere measurement of antibacterial activity is, however, no proof of the mode 
of antibacterial action.  For this reason, a means had to be found to isolate and 
measure that component of drug action which was dependent solely upon the 
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molecular orientation of a  tuberculostatic drug about the mycobacteria could 
enhance its antibacterial effect.  If such an increase of effect were noted, the 
validity of the hypothetical mechanism of drug action would be supported. 
In order to determine the increase in drug action due to its surface activity, 
recourse was had to another basic physical-chemical principle.  If two surface- 
active substances  are  in an  aqueous  system,  the  more highly surface-active 
compound will crowd the less active substance from the interface of such a 
system.  Applying  this principle  to  the problem at  hand,  a  more powerful 
surface-active substance in the form of Tween 80 could be added to the medium 
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FIG. 2 
in order to crowd the less active drug away from the periphery of the tubercle 
bacillus.  The surface-active sulfones would be adlineated around the acid-fast 
organisms, but when Tween 80 was added the sulfones would be displaced from 
this interface, and would therefore lose the component of drug action due to 
their molecular orientation.  In  this way the  component of drug action de- 
pendent  on  surface activity could be  selectively abolished  and  thereby ac- 
curately measured.  Non-surface-active drugs, on the other hand, would in no 
way be inhibited by Tween 80, thus furnishing an experimental control in the 
evaluation of drug action. 
EXPER~NTAL 
Method in Determining Tuberc~dostalic Potency of Drugs.--Serial  dilutions of a  number of 
surface-active  sulfones in appropriate liquid media were made in order to determine the rain- B.  EISEMAN  193 
imum concentration of drug required to inhibit the growth of various types of mycobacteria. 
A number of types of mycobacteria were tested in conjunction with the synthesized drugs 
as  well  as  with  controls.  These ranged from the saprophytic Mycobaaerium tuberculosis 
607 to the virulent human tt37Rv strain.  These organisms included.'* 
Mycobaaerium tuberculosis H37Rv 
Mycobacterium tuberculosis H37Ra 
Mycobacterium tuberculosis var. homlnls 607 
M ycobaaerium avium 
Mycobacterium tuberculosis var. bo~ 
Mycobacter~um phlei 
Mycobacterium stercoris 
As the work with these surface-active materials progressed, it was found that, in order to 
avoid errors in titer of drug action, a medium containing a minimum of surface-active material 
was required.  For this reason the Verwald modification of Proskauer-Beck synthetic medium 
was flsed at pH 7.2. 
Inoculations of mycobacteria other than the H37 strain were made with one loopfni of a 
72 hour growth.  The organisms were incubated at 37°C.  for 72 hours before being read. 
The 1-137 strain was grown on Dubos' albumin-oleate medium (15).  Inoculations were 
made with approximately 0.01  mg. of the organisms, the virulence of which had been main- 
tained by mouse passage.  Incubation was at 37°C.  for 10 days.  There usually was no dif- 
ference in readings between the 6th and 10th days, but the longer period was used as final. 
A series of surface-active sulfones was prepared by the Monsanto Chemical Co. according 
to the principles discussed above.  3  In order to make the surface-active properties of the drugs 
independent of pH variations, non-ionic or very slightly ionizing compounds were used. 
Table I  shows the chemical nature and formulae of the surface-active drugs used,  as well 
as the control drugs included for study.  All the compounds except diaminodiphenyl sulfone 
were water-soluble and were added in aqueous solution in the proper dilutions to the media. 
Ethylene glycol was used to dissolve the water-insoluble 4,4'-diaminodiphenyl sulfone. 
Surface tension determinations were made with a du Noiiy ring tensiometer.  The values 
for these determinations are given in Table II.  It is obvious from these determinations that 
the inhibitory effect of the drugs upon the growth of the tubercle bacillus is not simply by 
means of lowering the surface tension of the medium, for in no case was the surface tension at 
the level critical for mycobacterial growth, namely 35 to 40 dynes per sq. cm. 
Included in this study was pyricidin (sodium formaldehyde bisulfite of 5-amino-2-butoxy- 
pyridine), a  tuberculostatic agent recently described by Feinstone (16). 
Results of Tuberculostatic  Measurement.--In  general,  the  bacteriostatic  effi- 
ciency of each drug was  similar when tested with the various  types  of myco- 
bacteria.  This  finding  is  in  agreement  with previous  studies  (16,  17).  For 
this reason,  only the results obtained with the virulent H37Rv  human  strain 
are given, even though all the other mycobacteria were tested. 
2 The strains of Mycobacterlum tuberculosis H37Rv and H37Ra were kindly supplied by Mr. 
W. Steenken, Jr., from the Standard Cu!ture Depot Of the National Tuberculosis Association, 
Trudeau.  The other strains of mycobacteria were obtained from the American Type Culture 
Collection. 
3 It is a pleasure to acknowledge the help of Mr. Paul Logue, Dr. Paul Glusenkamp, and 
Mr. Milton Kosmin, all of the Monsanto Chemical Co., in the chemical problems involved 
in this study.  The surface-active sulfones were  synthesized under their direction at  the 
Central Research Department, Dayton. TABLE I 
No. 
10 
Name 
Sterox 1 
Sterox 2 
Sterox 3 
Sterox 4 
Sterox 5 
Sterox ? 
Sterox 6 
Sterox 8 
Sterox 9 
Sterox 10 
11  * 
12  Promin* 
13  Pyricidin$ 
Chemical formula 
H0  Cd~r-  (OC2H~)r-OC2H4--NH<~xS02 
H0  C2H.--  (0CtH~)  ~-0CtH~--NI-I~  / 
H0  Cslt,--(0Cd:I,)lr-0  S0aH. (2}NH~SO~NH, 
0 
HOC'H'  (CtH'0) ~0 C~I'0~CH2_.NHO  S~NH, 
HOC~Ht(CtH40 )  °OCsH40~CHr_NH~x" 
SOt 
HOC~I4  (C21~0)s.NH~  / 
HOC2H4  (CtH40)  ,CsH40--NH~  S~N--CH 
~  ~H 
OeFIz 
Chemical nature 
4, ¥-Diaminodiphenyl 
sulfone  ethylene  oxide 
condensation product 
Carbowax 600  sulfate  of 
4, 4'-diaminodiphenyl 
sulfone 
Same as sterox 2 but with 
less sulfone (50 per cent 
less of theoretical) 
4-Capryloylamino-4'- 
aminodiphenyl  sulfone 
plus ethylene oxide 
Condensation  of  chloro- 
methyl triton N]100 with 
4, 4'-diaminodiphenyl 
sulfone 
Same as sterox 5 but with 
added ethylene oxide 
Isovanillin  anil  of  4,4'- 
diaminodiphenyl sulfone 
HOC2H,(OC~H,)x~OCdt,CK/--~SO,~'---~  Condensation  product  of 
O__ (C~xLLO)u__CzH~OH  2, 4'-dlhydroxy dlphenyl 
sulfone  plus  ethylene 
oxide 
Same as above except a total of 20 tools of ethylene oxide instead of 24'  Condensation  product  of 
and a mixed isomer used  mixture  of  2,4'-  and 
4, 4'-dihydroxy diphenyl 
su~fone  with  ethylene 
oxide 
HOeHt CHr-  (O  C~H4)  nOCd~SO~. NH~  ~Ntts  4, 4'-Diaminodiphenyl sul- 
fone salt of polyethylene 
glycol sulfonic  acid 
NH~--~SO~/---~NH,  4, ¥-DiaminodiphenyI sub  -x  __./  -x  __/  fone 
HOCHKCHOH)~--~H--NH~ 
SO~-Xla 
SO~ 
SO~a  •  / 
I 
HOCH2 (CHOH)~--CH--NH~  / 
/~NHCHsSO~uN'a 
c~,o,,,/ 
N 
Sodium salt of 4,¥.dlam- 
diaminopidhenyl sulfone 
N.N'  di-  (dextrose suL 
fonate) 
Sodium formaldehyde bi- 
sulflte of  5-amino-2-bu- 
toxypyridine 
* Kindly supplied by Parke, Davis and Co., Detroit. 
~: Kindly supplied by the Pyridlum Corporation, Nepara Park, Yonkers. 
The remainder of the drugs were all synthesized by the Central Research Delmrtment of the Monsanto Chemical Co., 
Dayton. 
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As can be seen from Table III, the drugs vary widely in their tuberculostatic 
effect.  Most of the compounds are tuberculostafic in very low concentrations, 
TABLE  II 
Surface Tension of Drugs in Solution 
Drug 
Water ......................................................... 
Sterox 1 ....................................................... 
Sterox 2 ....................................................... 
Sterox 3 ....................................................... 
Sterox 4 ...................................................... 
Sterox 5 ...................................................... 
Sterox 6 ....................................................... 
Sterox 7 ....................................................... 
Sterox 8 ....................................................... 
Sterox 9 ....................................................... 
Sterox 10 ...................................................... 
Promin ........................................................ 
Pyricidin  ...................................................... 
Surface  tension  lOmg. 
per cent aqueous 
solution 
dynes/sq.cra. 
72 
6O 
59 
65 
45 
42 
53 
44 
59 
56 
51 
72 
55 
TABLE  III 
Tubcrculoaai~ Eff~ of Drugs 
Minimum  concentration 
Drug  inhibiting growth  of 
Mycobaaerium Lubcr- 
culosls H37Rv 
Sterox 
Sterox 
Sterox 
Sterox 
Sterox 
Sterox 
Sterox 
Sterox 
Sterox 
Sterox 10 ...................................................... 
Promin ........................................................ 
Diaminodiphenyl sulfone ......................................... 
Pyricidin ....................................................... 
1 ......................  ,  ................................ 
2 
3  ....................................................... 
4  ....................................................... 
5  ....................................................... 
6 
7 
8  ....................................................... 
9  ....................................................... 
rag. per cent 
20 
25 
1.0 
>2O 
0.07 
>20 
1.5 
>20 
>20 
0.6 
65 
0.5 
0.06 
and  are  effective in ranges well below  that  of promin.  Though  the absolute 
degree of effectiveness is not of major importance in supporting the hypothesis 
of  drug  action,  these  compounds  are  definitely  potent  tuberculostatic  sub- 
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Certain of the compounds are seen to be less active than  others.  In those 
cases in which  ethylene oxide was added in an effort to make the compound 
• more water-soluble, a  decrease in tuberculostasis is noted.  This is felt to be 
due to the fact that the previously unbound amino group on the sulfone is tied 
up  by  the  additional  ethylene  oxide.  As  has  been  demonstrated  with  the 
sulfonamides  (18),  such  a  condition decreases bacteriostatic activity, since a 
free amino group seems to be required for optimum action. 
In like manner, those compounds in which the sulfone is in the middle of the 
molecule--sterox, 1, 4, and 6--are of less absolute tuberculostatic value.  This 
may be due  to  the absence of a  free amino group,  as when  ethylene oxide is 
added.  On the other hand, such a  molcule would not have the active sulfone 
at  the  end  of  the  hydrophobic  portion  of  the  molecule  and  thus  might  be 
utilized less readily by the organism. 
Two compounds--sterox 8  and 9--were made in which dihydroxy diphenyl 
sulfone was used as the base, but neither of these substances was as effective as 
the diamino derivative. 
The most active of these compounds are those in which orientation of the 
molecule by means of its surface activity is assured.  Sterox 3,  sterox 5,  and 
sterox 10 are all effective against the mycobacteria, all have definite surface- 
active properties as gauged by their surface tension depressant action, and all 
have the sulfone on one end of the molecule.  These are conditions that,  ac- 
cording to the theory of drug action, might be required for most efficient action. 
The potency of pyricidin against the tubercle bacillus as stated by Feinstone 
(16) is confirmed in this study. 
Method in Evaluating Component of Drug Action Due to Its Surface Activity.--In order first 
to determine the qualitative effect of the highly surface-active Tween 80 upon the tuberculo- 
static action of the drugs, the minimum concentration inhibiting mycobacterial growth was 
determined in the presence of and in the absence of Tween 80.  This was accomplished by 
inoculating Mycobacterium tuberculosis var. hominis 607 into tubes of Proskauer-Beck  medium 
containing graded dilutions of the surface-active tuberculostatic agents.  Another comparable 
series was run with graded drug dilutions plus 0.05 per cent Tween 80 added to the medium. 
A comparison of the tuberculostatic activity  in the presence of andin the absence of Tween thus 
indicated the presence or absence of interference in drug activity. 
When large amounts of surface-active substances were present in the media, the organisms 
grew not as a surface pellicle, but as a submerged layer, or diffusely throughout the culture 
tube.  End-point determinations for inhibition of growth continued to be clear-cut, however. 
So that a more quantitative measure of this antagonistic action between the surface-active 
*drugs and the more highly surface-active Tween 80 could be made, tests of drug activity in 
the presence of varying concentrations of Tween 80 were carried out. 
A graded series of drug dilutions were added to a similar set of Tween 80 dilutions so that 
the amount of drug required for mycobacterial  inhibition could be determined for varying con- 
centrations of Tween 80.  Again Mycobacterium tuberculosis var. hominis 607 was used as the 
test organism in Proskauer-Beck medium.  As indicated in Fig. 3, two of the surface-active 
sulfo~es (sterox 3 and 5) as well as pyricidin were tested in the presence of varying concentra- 
tions of Tween 80.  The end-point in each series of dilutions was the minimum concentration ~.  ~zSm~Arr  197 
of drug that would inhibit the mycobacterial growth in the presence of the given Tween 80 
concentration. 
This type of experiment is similar to that carried out by Wood (19) in which the antagonistic 
action between the sulfonamides and paraaminobenzoic acid was tested.  In the case of the 
surface-active  sulfones, however, their  inhibition  is only partial, for but one component of 
drug action is neutralized, namely that portion due to its surface activity. 
Results  of  Tuberculostatic  Inhibition.--Table  IV  shows  the  results  of  the 
first  series  of experiments  in which  a  given  concentration  (0.05  per  cent)  of 
TABLE IV 
Difference in Tuberculostatic Effect in the Absence and in the Presence of 0.05 Per Cent Tween 80 
Number 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
Name 
Sterox 1 
Sterox 2 
Sterox 3 
Sterox 4 
Sterox 5 
Sterox 6 
Sterox 7 
Sterox 8 
Sterox 9 
Sterox 10 
Diaminodiphenyl sulfone 
Promin 
Pyricidin 
Per cent 
active 
principle 
of total 
molecular 
weight 
per cerd 
36 
27 
17 
19 
26 
37 
18 
19 
22 
28 
100 
31 
100 
Concentration inhibiting 
growth of Mycobactcrinm 
tuberculosls  var. komlnls 
607 
Proskauer- 
Proskauer-  Beck medium 
Beck  plus 0.05 per i 
medium  cent Tween 
80 
m&. per cent  rag.  per cent 
1.5  200 
0.9  150 
0.4  200 
>20  200 
0.2  75 
>20  200 
0.5  150 
>20  200 
20  200 
0.75  150 
0.072  0.072 
4.0  5.0 
0.062  25 
Difference 
in activity 
when sur- 
face action 
of drug is 
abolished 
by Tween 
80 
130  X 
166  X 
500  X 
375  X 
300  X 
200  X 
None 
Negligible 
403  X 
Tween 80 was used to determine qualitatively whether any inhibition in drug 
effect  was  attained  by  the  highly  surface-active  oleate.  As can  be  seen,  a 
great  discrepancy  exists  between  the  tuberculostatic  powers  of  the  surface- 
active sulfones in the absence of and in the presence of the more highly active, 
and growth-promoting Tween 80.  In the case of sterox 3 there was a decrease 
of 500 times in drug activity when 0.05 per cent Tween 80 was present.  By 
partially  interfering  with  the  molecular  orientation  of  the  drug  about  the 
bacteria, therefore, the activity of the drug was decreased 500 times.  Stating 
the situation in a reverse manner, it could be said that making the drug surface- 
active with its resultant  steric arrangement about the organism, increases its 
tuberculostatic action 500 times. 
It is quite evident from these data that no appreciable inhibitory effect is had 198  TUBERCULOSTATIC  E!~FECT O]~ CIIEI~OTIIERAPEUTIC AGENTS 
upon those drugs that are not in themselves surface-active.  Diaminodiphenyl 
sulfone,  and  promine  are  not  affected,  whereas  the  various  surface-active 
sulfones and pyricidin  are markedly inhibited  in  their bacteriostatic effect by 
these surface-active antagonists.  It would seem that this furnishes  a  method 
of  differentiating  the  mechanism  of  drug  action  between  those  compounds 
which rely for their action to some extent on their surface  activity from those 
compounds which do not have this physicochemical property as a basis of their 
activity 
10-4 
g 
g 
~ IO  -~ 
~ 10-6 
~ IO  -~ 
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FIO. 3.  Inhibition of tuberculostatic action of surface-active drugs by more highly surface- 
active Tween 80. 
More  precise  and  quantitative  measurements  of  this  tuberculostatic  an- 
tagonism are recorded in Fig.  3.  In  this  experiment the two most effective 
surface-active sulfones (sterox 3 and 5) as well as pyricidin were tested in the 
Presence  of varying  concentrations  of  Tween 80.  The  tuberculostatic  end- 
points in this experiment are plotted as a  function of the Tween 80 and drug 
concentrations. 
In very low concentrations  of Tween 80 there is no inhibiting  effect upon 
drug action--the fiat part of the curve where a  minimum of drug was needed 
to cause bacteriostasis.  As more Tween 80 was added, however, an increased 
amount of drug was required to inhibit bacterial growth.  At a  certain point 
the addition of more Tween 80 caused no further diminution in the effect of the 
drug, and at this point the curve leveled off. ]3.  ]~ISE~A-~  199 
Non-surface-active  drugs are not antagonized in their bacteriostatic action 
by  Tween  80.  Graphically,  such  substances  as  promin,  diaminodiphenyl 
sulfone, and sodium azide  produce a  straight horizontal line  in experiments 
such as that illustrated in Fig. 3 for their action is independent of Tween 80 
concentration.  At that point where the steric concentration component of the 
surface-active  drugs is abolished,  they too act like non-surface-active  drugs, 
thus accounting for the leveling of the curve in Fig.  3.  4  Returning to  the 
physical-chemical principles involved, the antagonistic action between the two 
surface-active substances in the form of Tween 80 and the surface-active drugs, 
may be pictured as a competition  for a place at the mycobacterial boundary. 
Increasing concentrations of Tween push the less surface-active  drug from the 
bacterial cell back into the surrounding  medium.  At a  certain point, all of 
the surface-active  drug would be pushed from this interface and further addi- 
tion of Tween 80 would assert no more effect.  At this point the curve flattens 
out on the graph,  for the surface-active  component of the drug has been en- 
• tirely abolished and its action is  that of any non-surface-active  agent: it is 
bacteriostatic when metabolized  by the organism, but has no particular steric 
adlineation around the bacillus. 
DISCUSSION 
The  Surface-Active  Component  in  Some  Previously  Described Bacteriostatic 
Substances.--In  support of the mode of drug action described  above,  several 
drugs previously reported in the literature can be cited  (22).  If molecular 
orientation  about  an  organism  by  reason  of  surface-active  properties  en- 
hances the bacteriostatic effect of a  drug,  then drugs having any degree  of 
such surface activity should demonstrate the principle involved.  Such drugs 
were found and their mode of action proven to be similar to that of the syn- 
thesized surface-active sulfones. 
Feinstone (16) recently has introduced a new series of potent tuberculostatic 
substances.  He discussed the efficiency of such substances  but has not sug- 
gested the mode of action of the compounds.  The drug showing the greatest 
promise, according to the author, was sodium formaldehyde  bisulfite of 5-amino- 
2-butoxypyridine.  This drug has been called pyricidin by its manufacturer. 
Examination of the chemical nature of this drug (Table  I)  suggests that the 
compound would have surface-active  properties,  and it does, as a  matter of 
fact, lower surface tension of an aqueous solution markedly, as shown in Table 
II. 
Just as the surface-active sulfones were described as concentrating about the 
mycobacteria, so the surface-active pyricidin molecules can be pictured at the 
bacterial interface.  In the latter case, an entirely different hydrophobic and 
* Far from being antogonized, the action of some non-surface-active bacteriostatic sub- 
stances is enhanced by the addition of surface-active agents.  This is probably due to the 
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tuberculostatic material is concentrated around or within the cell, consisting of 
a  pyridine nucleus instead of a sulfone.  Though the basic mode of metabolic 
inhibition with the two drugs is probably very different, they are concentrated 
about  the  organism  in  a  similar  fashion--by means  of  their  surface-active 
properties. 
That pyricidin does indeed owe some of its activity to its molecular concen- 
tration about the bacteria is shown in the similarity of its experimental behavior 
to that  of the  surface-active sulfones.  This is evident from examination of 
Fig.  3  and Table IV.  The bacteriostatic activity of both pyricidin and the 
surface-active sulfones is diminished when their steric arrangement in regard 
to the bacterial boundary is disturbed.  Under these conditions, both groups 
of drugs maintain a bacteriostatic effect, but one which is much less than is the 
case when their surface-active properties are allowed to come into play.  Both 
therefore appear to have their antibacterial action enhanced by reason of their 
surface activity. 
Another group of tuberculostatic substances that have surface-active prop- 
erties has been introduced by Freediander (23).  This author has studied  the 
chemotherapeutic properties of certain sulionium and iodonium salts which he 
has  noted  in  passing  are  to  some  degree  surface-active.  He  further states 
that,  though the sulfonium  and  iodonium compounds  belong to the class of 
cationic surface-active substances,  their action is not  that  of the  commonly 
used germicidal detergents.  It would seem that the mechanism of  action of 
this group of tuberculostatic agents might in part be explained by their property 
of surface activity, as in the case of pyricidin. 
Certain  of  the  antibiotics  also  are  found  to  be  surface-active,  and  their 
activity must  be  considered in  the  light  of the  physical-chemical principles 
herein described.  Graraicidin (24) and its various breakdown products (25, 26) 
have  marked  surface-active  properties.  The  antibiotic  subtilin  is  likewise 
reported to  be  surface-active  (27).  Although  the  exact  chemical nature  of 
these antibiotics is not known, the surface-active molecules may be pictured 
as  concentrating about  an  organism in  a  manner analogous  to  that  of  the 
chemically simpler surface-active drugs. 
Surface-Active  Bacteriostatic  Agents  in  Contrast  to  the  Detergents.--Since 
Domagk  (28)  first observed the bactericidal action of certain cationic deter- 
gents,  a  vast  literature  on  this  subject  has  accumulated.  Many  cationic 
surface-active agents are commercially available (zephiran, phemerol, ceepryn, 
etc.) and have found wise use as topical germicides.  They have unfortunately 
a non-specific cytolytic action, effectively disintegrating not only bacteria, but 
tissue cells as well.  For this reason their systemic use is precluded. 
The surface-active bacteriostatic agents used in this study owe their essential 
antibacterial activity to properties other than mere cell destruction.  Their 
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compound from which they are derived--in the case of the drugs used in this 
study,  that  of the  sulfone.  They function  therefore as  selective inhibitors, 
blocking enzyme systems that are vital for bacterial growth, but are relatively 
less important to tissue cell metabolism.  The surface-active properties of such 
drugs effectively increase their apparent  antibacterial activity but they con- 
tinue to operate in a manner which makes them more toxic to bacteria than to 
host cells.  The active hydrophobic end of the surface-active drug may ap- 
proach many cells but is relatively toxic only to the bacteria.  Instead of being 
classed with the cationic detergents as general protoplasmic poisons,  therefore, 
these substances may be considered chemotherapeutic agents. 
Bactericidal-Wetting Agent Mixtures.--Simple  mixtures  of various types of 
bactericidal and bacteriostatic drugs with surface-active substances have been 
investigated by many authors (21, 29-33).  The consensus of opinion has been 
that a potentiation of bactericidal effect is obtained by means of these mixtures 
(20).  The mechanism of such action is felt to be due to the wetting action of 
the detergent upon the bacteria, thus sponsoring  closer contact between drug 
and organism (34). 
The use of mixtures of drugs and wetting agents is, of course,  a  condition 
different  from  the  employment of a  single  molecular  compound  containing 
both bacteriostatic  and  surface-active  properties.  Wetting  of  the  bacteria 
may not necessarily produce closer  contact between drug and  organism,  for 
the bacteriostatic agent is in no way attached to the surface-active molecule 
that  coats the bacteria.  Contact between drug  and  bacteria would in  this 
case depend upon the interaction between the drug and the wetting agent, as 
well as on the nature of the organism  involved.  If, on the other hand,  one 
molecule combined the  two characteristics  of surface activity and  bacterio- 
static action, such condition of contact is assured. 
Applications of These Principles of Drug Activity.--If  these  principles  of 
drug activity should be confirmed, their application to various types of chemo- 
therapeutic  agents  should  be  feasible.  Surface-active  properties  can  be 
relatively easily imparted  to many types of molecules.  In the case of anti- 
bacterial drugs, this of course may change the essential metabolic activity of 
the compound, and this effect would have to be considered  in drug synthesis. 
Because of their high lipid content, only mycobacteria have been included in 
this study.  The physical-chemical principles involved, however, are equally 
applicable to other types of organisms,  though according  to Feinstone's results 
with pyricidin (16), the drug is much less effective against organisms other than 
mycobacteria. 
Since the surface-active properties of these drugs need be relatively slight in 
order to assure their molecular orientation,  their toxicity in this respect may 
not be great.  The bacterial inhibition that they induce is not dependent solely 
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none of the cytolytic properties of the strong detergents.  In vitro experiments 
with the drugs used in this sereis,  for example, demonstrate that many times 
the  concentration  required  for  tubercle  bacillus  inhibition  is  necessary  to 
initiate hemolysis. 
SUMMARy  AND  CONCLUSIONS 
By incorporating a known tuberculostatic agent on one end of a surface- 
active molecule, an increased in vitro effect  on the tubercle bacillus has been 
obtained. 
This activity is presumably due to the concentration  of the drug molecules 
at or beneath the mycobacterial  cell boundary. 
Whether the  surface-active drug actually penetrates the  lipid, or  lipo- 
protein complex that is so characteristic of the mycobacteria  is only  problem- 
atic.  According  to comparable purely physical-chemical  experiments, such a 
penetration is quite likely. 
Increase in  tuberculostatic effect of over 1000-fold has been attained by 
rendering surface-active the drugs included in this study. The quantitative 
evaluation of this increase in activity has been obtained by measuring drug 
action both when its surface-active  properties are functional,  and when these 
properties have been selectively abolished by  a  specific surface-active an- 
tagonist. 
It is believed that the molecular  orientation  of a sudace-active  drug about a 
bacterial cell  accounts for ol~e component of its antibacterial action.  Certain 
previously described surface-active  antituberculous  drugs and antibiotics  have 
been examined  in light of this  interpretation. 
It may be anticipated that the more potent tuberculostatic  drugs such as 
streptomycin could  be made more effective  by incorporating the molecule into 
a surface-active  compound, according  to the principles herein described. 
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